CiRC Biosciences

Chicago, IL · Founded 2019 · Privately Held (backing)

Developer of cell-based therapies designed to offer treatments for serious diseases with high unmet needs, with an initial focus on blindness. CiRC Biosciences is based in Chicago, IL and was founded in 2019. Its last reported valuation was $24 million in Dec 2020. It has raised $39.1 million across 2 recorded rounds; the latest was a $7 million debt round in Apr 2024.

Last reported valuation
$24.0M
Oct 2026
Priced at
—
Total raised
$39.1M
Last round
Debt
Apr 2024
How much has CiRC Biosciences raised?
$39.1Macross 2 recorded rounds · Feb 2024 – Apr 2024

Most recently, CiRC Biosciences raised $7.0M in its Debt (Apr 2024).

Free account
More of CiRC Biosciences with a free account
  • ·Watch CiRC Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CiRC Biosciences round by round

2 rounds
Apr 2024Debt$7.0MSEC filing▮
19 investors participated
Feb 2024Seed Round$250KSEC filing▮
1 investors participated

How much has CiRC Biosciences raised?

CiRC Biosciences has raised $39.1 million in total; 2 of its rounds are on record. The largest on record was a $7 million debt round in Apr 2024.

CiRC Biosciences has filed 2 Form Ds with the SEC, most recently in Oct 2024 ($250,000 sold to 1 investor).

CiRC Biosciences investors

5 investors are on record for CiRC Biosciences, including Valor Equity Partners, HSC Next, Harmony Biosciences Holdings and Paragon Biosciences. The debt round in Apr 2024 drew 19 investors.

For fundraisers
Raising for a company like CiRC Biosciences?

5 investors have backed CiRC Biosciences.

See all 5 investors →

Frequently asked about CiRC Biosciences

How much has CiRC Biosciences raised?
CiRC Biosciences has raised $39.1M in total across 2 recorded funding rounds.
When was CiRC Biosciences's last funding round?
CiRC Biosciences's most recent recorded round was Debt in Apr 2024, raising $7.0M.